Axalta Coating Systems Ltd. AXTA
Composite 51/100; the shares have moved about 37% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 38/100 — a slight mark against it.
Momentum ranks 64/100 — a moderate point in its favour. Valuation ranks 55/100 — a slight point in its favour. Quality ranks 54/100 — a slight point in its favour.
Growth ranks 38/100 — a slight mark against it. Balance-sheet strength ranks 44/100 — a slight mark against it.
What the company does Axalta Coating Systems manufactures and markets high-performance coatings for automotive refinish, commercial vehicles, and industrial applications. Its segments include Performance Coatings (repair coatings) and Mobility Coatings (OEM vehicle coatings). The company serves global markets with brands like Imron Industrial and Alesta.
Key financials Axalta reports gross margins of 34.2%, operating margins of 13.6%, and net margins of 7.2%. ROE is 16.2% and ROA is 6.4%. Revenue declined -0.6% YoY, while EPS fell -6.7%. Debt/Equity stands at 1.19 with a net debt/EBITDA of 2.46.
Stock health The stock shows strong momentum with 3m +27.72%, 6m +5.78%, and 12m +25.54% gains. RSI(14) is 65.60, indicating near overbought conditions. Sideravia scores it 52.2 overall, with Valuation at 68.3 and Momentum at 65.8.
Price vs fair value The stock trades at a PREMIUM of 55.00% versus our fair-value estimate of 16.23 and at a discount of 7.05% versus the 12-month target of 38.57. - Q2 earnings topped estimates on volume and pricing growth (Zacks). - Shares gained after Q2 EBITDA growth was highlighted (GuruFocus.com). - Analysts note outperformance vs peers this year (Zacks).
Looking forward Forward P/E is 12.14 with a PEG of 0.21, suggesting potential value despite premium pricing. Analysts cite strong EBITDA growth and revenue beats as key drivers. However, margins and revenue growth remain under pressure.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.